BROS shareholder files Form 144 to sell 317,125 founder shares

Rhea-AI Filing Summary

A shareholder of BROS filed a Form 144 notice to potentially sell 317,125 shares of common stock through Morgan Stanley Smith Barney LLC on or about 11/24/2025 on the NYSE. The shares to be sold have an stated aggregate market value of $17,391,135.00, and the filing notes 127,031,344 shares of common stock outstanding.

The securities are described as founder shares, acquired from the issuer on 09/27/2018 and fully paid on the same date. Over the prior three months, related Rule 10b5-1 sales included 304,113 shares of common stock for gross proceeds of $20,966,523.38 and 483,568 shares for gross proceeds of $33,338,725.34. The signer represents that they are not aware of undisclosed material adverse information about the issuer’s operations.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	317125	17391135.00	127031344	11/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/27/2018	Founders Shares	Issuer			317125	09/27/2018	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DM INDIVIDUAL AGGREGATOR, LLC 1930 W. Rio Salado Pkwy Tempe AZ 85281	Common	08/25/2025	304113	20966523.38
10b5-1 Sales for DM TRUST AGGREGATOR, LLC 1930 W. Rio Salado Pkwy Tempe AZ 85281	Common	08/25/2025	483568	33338725.34

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BROS Form 144 filing disclose?

The Form 144 discloses that a shareholder of BROS intends to sell up to 317,125 shares of common stock on the NYSE, with an aggregate market value of $17,391,135.00, through Morgan Stanley Smith Barney LLC.

How many BROS shares are planned to be sold under this Form 144?

The filing indicates that up to 317,125 shares of BROS common stock are planned to be sold.

What is the approximate sale date and market for the BROS shares?

The Form 144 lists an approximate sale date of 11/24/2025, with the BROS common stock to be sold on the NYSE.

What does the Form 144 say about recent BROS share sales by related entities?

Over the past three months, the filing reports Rule 10b5-1 sales of 304,113 shares for gross proceeds of $20,966,523.38 and 483,568 shares for gross proceeds of $33,338,725.34 by related entities.

How and when were the BROS shares in this Form 144 originally acquired?

The 317,125 shares to be sold are described as founder shares, acquired from the issuer on 09/27/2018, with payment completed on the same date.

How many BROS shares are indicated as outstanding in the Form 144?

The notice states that 127,031,344 shares of BROS common stock were outstanding, providing a baseline for the planned sale.

What representation does the seller make about information on BROS?

By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.